Lineage Cell Therapeutics
LCTX
LCTX
74 hedge funds and large institutions have $98.5M invested in Lineage Cell Therapeutics in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 24
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
78% less call options, than puts
Call options by funds: $113K | Put options by funds: $508K
Holders
74
Holding in Top 10
1
Calls
$113K
Puts
$508K
Top Buyers
| 1 | +$7.29M | |
| 2 | +$604K | |
| 3 | +$376K | |
| 4 |
V
Veritable
Wilmington,
Delaware
|
+$225K |
| 5 |
SFA
Sequoia Financial Advisors
Akron,
Ohio
|
+$135K |
Top Sellers
| 1 | -$721K | |
| 2 | -$599K | |
| 3 | -$411K | |
| 4 |
CCM
Consonance Capital Management
New York
|
-$348K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$234K |